Clinical implementation of targeted and immunotherapies for advanced RCC

Episode 1 December 14, 2022 00:19:51
Clinical implementation of targeted and immunotherapies for advanced RCC
COR2ED Medical Education
Clinical implementation of targeted and immunotherapies for advanced RCC

Dec 14 2022 | 00:19:51

/

Show Notes

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of Brest and Quimper in France, discuss the clinical implementation of targeted and immunotherapies for advanced renal cell carcinoma (RCC).

In this podcast, the two experts discuss data from key trials CHECKMATE 214 (ipilimumab and nivolumab), KEYNOTE 426 (axitinib and pembrolizumab), CHECKMATE 9ER (cabozantinib and nivolumab), CLEAR (Lenvatinib and pembrolizumab) and COSMIC 313 (cabozantinib plus nivolumab and ipilimumab) and the implications for clinical practice.

They also discuss management of toxicities associated with combination treatments, including dosing strategies to ensure the patient remains on optimal treatment and improved education for patients and clinicians so that they recognise side effects and how to manage them.

Other Episodes

Episode 1

November 30, 2021 00:20:49
Episode Cover

The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Prof. Georg Hutterer, a Urologist from the Medical University of...

Listen

Episode 1

November 18, 2022 00:32:39
Episode Cover

The role of SSA at progression – to continue or not?

COR2ED Medical Education: In this podcast, Prof. Martyn Caplin and Dr Aman Chauhan discuss the role of somatostatin analogues (SSAs) at progression and whether...

Listen

Episode 1

March 03, 2022 00:28:12
Episode Cover

Prophylaxis in children with haemophilia

COR2ED Medical Education: Prof. Karin Fijnvandraat, Professor of Paediatric Haematology at the University of Amsterdam in the Netherlands and Dr. Maria Elisa Mancuso, Senior...

Listen